Board approves preferential issue of shares and warrants, subsidiary divestment
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 4.6 pts more than its Software Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Board approved preferential issue of 11,70,000 equity shares at Rs 10 each to 12 non-promoter investors and 20,00,000 convertible warrants at Rs 10 each to 4 promoter group allottees including Managing Director Divyesh Boda. Also approved sale of two subsidiaries Life 108 Healthcare and Beastbells Media to Director Ms. Vijaya Lakshmi Boda for about Rs 4.37 crore as a related party deal. New independent director Mr. Annapantula Seetarama Murthy appointed, Mr. Ajit Kumar Nagrani retired after completing second term. Secretarial auditor reappointed for 5 years. All items subject to shareholder approval at AGM on September 30 2026.
Equity dilution from preferential issue and warrants (about 10 percent to non-promoters plus warrants dilution later); subsidiary sale to director is a related party transaction needing shareholder approval.